Cantitate/Preț
Produs

Biomarkers in Urology, An Issue of Urologic Clinics: The Clinics: Surgery, cartea 50-1

Editat de Adam Feldman
en Limba Engleză Hardback – 22 noi 2022
In this issue of Urologic Clinics of North America, guest editor Dr. Adam Feldman brings his considerable expertise to the topic of Biomarkers in Urology. The use of biomarkers in clinical practice can range from screening, to refined detection in an at-risk population, to risk stratification following diagnosis, to prognostication following therapy. A better understanding of tumor biology and genetic heterogeneity will lead clinicians to adopt clinical paradigms that utilize sequences of biomarker assessments. In this issue, key experts help you remain at the forefront of the care of urologic malignancies by providing a timely update on emerging biomarkers in urology.
Citește tot Restrânge

Din seria The Clinics: Surgery

Preț: 63546 lei

Preț vechi: 66890 lei
-5% Nou

Puncte Express: 953

Preț estimativ în valută:
12162 12830$ 10135£

Carte disponibilă

Livrare economică 12-26 decembrie
Livrare express 27 noiembrie-03 decembrie pentru 3692 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323940191
ISBN-10: 0323940196
Pagini: 240
Dimensiuni: 178 x 254 x 15 mm
Greutate: 0.53 kg
Editura: Elsevier
Seria The Clinics: Surgery


Cuprins

Approaches and Barriers to Biomarker Discovery: The Example of Biomarkers of Renal Scarring in Pediatric Urology
Biomarkers in Urolithiasis
Biomarkers in Urethral Stricture Disease and Benign Lower Urinary Tract Disease
Pathophysiology and Clinical Biomarkers in Interstitial Cystitis
Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-Muscle-Invasive Bladder Cancer
Biological Stratification of Invasive and Advanced Urothelial Carcinoma
The Association Between the Urinary Microbiome and Bladder Cancer
Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
Targeted Molecular Imaging as a Biomarker in Urologic Oncology
Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond
The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer
Current and Future Biomarkers in the Management of Renal Cell Carcinoma